BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8682036)

  • 1. Left ventricular systolic function after marked reduction of ventricular hypertrophy induced by 5 years' enalapril treatment.
    González-Juanatey JR; Pose Reino A; García Acuña JM; Castelo Fuentes V; Amaro Gendón A; Calvo Gómez C; Gil de la Peña M
    Eur Heart J; 1995 Dec; 16(12):1981-7. PubMed ID: 8682036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preserved ventricular pump function after a marked reduction of left ventricular mass.
    Ketelhut R; Franz IW; Behr U; Toennesmann U; Messerli FH
    J Am Coll Cardiol; 1992 Oct; 20(4):864-8. PubMed ID: 1356116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril.
    González-Juanatey JR; García-Acuña JM; Pose A; Varela A; Calvo C; Cabezas-Cerrato J; de la Peña MG
    Am J Cardiol; 1998 Jan; 81(2):170-4. PubMed ID: 9591900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of left ventricular hypertrophy in previously untreated essential hypertension: different effects of enalapril and hydrochlorothiazide.
    Dahlöf B; Hansson L
    J Hypertens; 1992 Dec; 10(12):1513-24. PubMed ID: 1338083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converting enzyme inhibition and left ventricular hypertrophy.
    Fagard R
    Eur Heart J; 1995 Dec; 16(12):1748-9. PubMed ID: 8681996
    [No Abstract]   [Full Text] [Related]  

  • 6. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
    Dyadyk AI; Bagriy AE; Lebed IA; Yarovaya NF; Schukina EV; Taradin GG
    Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of blood pressure control and left ventricular performance with small doses of enalapril.
    González-Juanatey JR; Reino AP; García-Acuña JM; González-Juanatey C; Valdes L; de la Peña MG; Cabezas-Cerrato J
    Am J Cardiol; 1999 Mar; 83(5):719-23. PubMed ID: 10080425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade.
    van den Heuvel AF; Dunselman PH; Kingma T; Verhorst P; Boomsma F; van Gilst WH; van Veldhuisen DJ
    J Am Coll Cardiol; 2001 Feb; 37(2):470-4. PubMed ID: 11216965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term improvement of QT dispersion is unaffected by short-term changes in blood pressure during treatment of systemic hypertension with enalapril.
    Seara FJ; Juanatey JR; Sande JL; Veloso PR; Reino AP; Román AV; Cerrato JC; Peña MG
    Ann Noninvasive Electrocardiol; 2003 Jan; 8(1):47-54. PubMed ID: 12848813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy and renal function in hypertensive patients.
    De Rosa ML; Cardace P; Rossi M; Baiano A; de Cristofaro A
    J Hum Hypertens; 2002 Feb; 16(2):133-40. PubMed ID: 11850771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
    Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
    Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
    Avanza AC; El Aouar LM; Mill JG
    Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension.
    Gerritsen TA; Bak AA; Stolk RP; Jonker JJ; Grobbee DE
    J Hypertens; 1998 May; 16(5):689-96. PubMed ID: 9797181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of enalapril in cats with pressure overload-induced left ventricular hypertrophy.
    Ishikawa Y; Uechi M; Hori Y; Takashi Ebisawa ; Yamano S; Enomoto Y; Jun Ugai
    J Feline Med Surg; 2007 Feb; 9(1):29-35. PubMed ID: 16934512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical- functional assessment of organoprotective efficacy of enalapril and telmisartan in patients with arterial hypertension].
    Tatarchenko IP; Pozdniakova NV; Morozova OI; Petrushin IA; Sekerko SA
    Kardiologiia; 2011; 51(4):16-21. PubMed ID: 21623715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
    Gosse P; Roudaut R; Herrero G; Dallocchio M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril.
    Hadi NR; Abdulzahra MS; Al-Huseini LM; Al-Aubaidy HA
    Int J Cardiol; 2017 Mar; 230():269-274. PubMed ID: 28041700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ACE inhibition on left ventricular dimensions and haemodynamics in systemic hypertension: a radionuclide and echocardiographic study.
    Haznedaroglu IC; Erdem Y; Tokgözoglu L; Caglar M; Kes S; Sayinalp NM; Yörükan S
    Cent Afr J Med; 1995 Apr; 41(4):118-23. PubMed ID: 7788682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Losartan versus enalapril in the reduction of left ventricular hypertrophy secondary to systemic arterial hypertension].
    Uribe Flores JD; Hernández Jácome M; Guevara Dondé J; Segura X
    Arch Cardiol Mex; 2004; 74(3):192-9. PubMed ID: 15559871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.